Pharmacokinetics and Pharmacodynamics Practice Questions

Q: If a drug has a Volume of Distribution (Vd) equal to 60L, what does this indicate about the drug's distribution?

The drug is significantly sequestered in tissue sites.. **Explanation:** The **Volume of Distribution (Vd)** is a theoretical volume that relates the total amount of drug in the body to its concentration in the plasma ($Vd = \text{Total amount of drug} / \text{Plasma concentration}$) [1]. In an average 70 kg adult, the total body water is approximately **42 liters** [1]. * **Plasma volume:** ~3-4 L [1] * **Extracellular fluid:** ~14 L [1] * **Total body water:** ~42 L [1] If a drug has a **Vd of 60L**, it exceeds the total body water (42L). This indicates that the drug is not confined to the plasma or extracellular fluid but has distributed extensively into the tissues [1]. A high Vd suggests the drug is **lipid-soluble** and is being **sequestered in tissue sites** (like fat, muscle, or specific organs), resulting in a very low plasma concentration [1]. **Analysis of Incorrect Options:** * **Option B:** High plasma protein binding keeps the drug confined to the vascular compartment, resulting in a **low Vd** (e.g., Warfarin, Vd ≈ 8L) [1]. * **Option C:** Vd relates to distribution, not directly to the rate of excretion. However, drugs with a high Vd are often harder to remove via hemodialysis because they are hidden in tissues rather than circulating in the blood. **NEET-PG High-Yield Pearls:** 1. **Low Vd ( 42L):** Drug is sequestered in tissues (e.g., Digoxin, Chloroquine) [1]. **Chloroquine** has a massive Vd (~13,000L) due to high tissue binding [1]. 3. **Loading Dose Calculation:** $LD = Vd \times \text{Target Plasma Concentration}$. Drugs with high Vd require a higher loading dose to achieve therapeutic levels.

Q: Which of the following drugs is NOT metabolized by acetylation?

Metoclopramide. The correct answer is **Metoclopramide**. **Metoclopramide** is primarily metabolized in the liver via **glucuronidation and sulfation**, not acetylation. It is a dopamine D2 receptor antagonist used as a prokinetic and antiemetic. **Acetylation** is a Phase II metabolic reaction catalyzed by the enzyme **N-acetyltransferase (NAT)**. Drugs metabolized by this pathway are subject to genetic polymorphism, dividing the population into "Fast Acetylators" and "Slow Acetylators." **Why the other options are incorrect:** * **Isoniazid (INH):** The classic example of an acetylated drug. Slow acetylators are at a higher risk of peripheral neuropathy, while fast acetylators may develop hepatotoxicity. * **Dapsone:** Used in leprosy; it is metabolized by acetylation. Slow acetylators are more prone to hematological side effects like methemoglobinemia. * **Hydralazine:** An antihypertensive that undergoes significant first-pass metabolism via acetylation. **High-Yield Clinical Pearls for NEET-PG:** To remember the drugs metabolized by acetylation, use the mnemonic **"SHIP"**: * **S** – Sulfonamides (e.g., Sulfasalazine, Dapsone) * **H** – Hydralazine * **I** – Isoniazid * **P** – Procainamide **Key Concept:** Slow acetylators are at an increased risk of **Drug-Induced Lupus Erythematosus (DILE)**, particularly when taking Hydralazine or Procainamide. Metoclopramide does not cause this because it bypasses the acetylation pathway.

Q: What causes the rapid awakening from a single bolus dose of Propofol?

Redistribution. **Explanation:** The rapid recovery from a single bolus dose of Propofol is due to **Redistribution**, not metabolism or excretion. **1. Why Redistribution is Correct:** Propofol is a highly lipid-soluble drug. Upon intravenous administration, it rapidly reaches organs with high blood flow (the **vessel-rich group**), primarily the brain, leading to a quick induction of anesthesia. However, as plasma levels fall, the drug quickly moves out of the brain and "redistributes" into less vascular but high-capacity tissues like skeletal muscle and adipose tissue. Since the concentration in the brain drops below the therapeutic threshold, the patient awakens within 5–10 minutes, even though the drug is still present in the body. **2. Why Other Options are Incorrect:** * **Excretion:** Renal or biliary clearance is too slow to account for the immediate awakening (minutes) seen with Propofol. * **Biotransformation (Metabolism):** While Propofol is rapidly metabolized by the liver (glucuronidation), the rate of metabolism does not match the speed of recovery from a single bolus. Metabolism determines the *elimination* half-life, whereas redistribution determines the *distribution* half-life ($\alpha$-half-life). * **D-Methylation:** This is not a primary metabolic pathway for Propofol. **High-Yield Clinical Pearls for NEET-PG:** * **Context-Sensitive Half-Time:** While recovery from a *bolus* is due to redistribution, recovery from a *prolonged infusion* depends on metabolism, as peripheral tissues become saturated. * **Propofol Infusion Syndrome (PRIS):** A rare, fatal complication of long-term high-dose infusion characterized by metabolic acidosis, rhabdomyolysis, and cardiac failure. * **Drug of Choice:** Propofol is the preferred agent for Day Care Surgery due to its rapid recovery and anti-emetic properties.

Q: A drug administered through which of the following routes undergoes high first-pass metabolism?

Oral. **Explanation:** **1. Why Oral is Correct:** The oral route is the most common route associated with high **first-pass metabolism** (presystemic metabolism). When a drug is swallowed, it is absorbed from the gastrointestinal tract into the **portal venous system**. Before reaching the systemic circulation, the drug must pass through the **liver**, which is the primary site for drug metabolism. If the liver enzymes (like Cytochrome P450) metabolize a significant fraction of the drug during this initial passage, its bioavailability is drastically reduced. **2. Why Incorrect Options are Wrong:** * **Sublingual:** Drugs absorbed through the buccal mucosa drain directly into the superior vena cava, bypassing the portal circulation and the liver. This ensures rapid action and higher bioavailability (e.g., Nitroglycerin). * **Intravenous (I.V.):** This route bypasses all absorption barriers and the liver initially, delivering 100% of the drug directly into the systemic circulation. * **Intramuscular (I.M.):** The drug is absorbed from the muscle capillaries into the systemic venous return, bypassing the portal system and avoiding first-pass metabolism. **3. High-Yield Clinical Pearls for NEET-PG:** * **Definition:** First-pass metabolism occurs in the gut wall, portal vein, and most significantly, the **liver**. * **Drugs with high first-pass metabolism:** Nitroglycerin (hence given sublingually), Propranolol, Lidocaine, Morphine, and Salbutamol. * **Rectal Route:** Only the upper part of the rectum drains into the portal system; the lower part drains into the systemic veins. Therefore, the rectal route **partially** bypasses first-pass metabolism (~50%). * **Bioavailability (F):** High first-pass metabolism leads to low bioavailability. It is calculated as: $F = \text{Fraction absorbed} \times (1 - \text{Extraction ratio})$.

Q: Which of the following statements regarding transfer of drugs across the placenta is FALSE?

Ion trapping of acidic drugs occurs in the placenta.. **Explanation:** The transfer of drugs across the placenta is governed by lipid solubility, molecular weight, and the pH gradient between maternal and fetal blood. **1. Why Option C is the Correct (False) Statement:** The fetal blood is slightly more **acidic** (pH ~7.3) than maternal blood (pH ~7.4). According to the pH partition hypothesis, **basic drugs** (like local anesthetics or opioids) cross the placenta in an uncharged state and become ionized in the relatively acidic fetal environment. Once ionized, they cannot diffuse back into the maternal circulation, leading to accumulation. This is known as **ion trapping of basic drugs**, not acidic drugs. Acidic drugs remain largely unionized in the maternal blood and do not "trap" in the fetus. **2. Analysis of Other Options:** * **Option A:** In early pregnancy, the placental membrane is thicker and the surface area is smaller. As pregnancy progresses, the membrane thins and surface area increases, making drug transfer **greater in late pregnancy** and lesser in early pregnancy. * **Option B:** Most drugs cross the placenta via simple diffusion. Large molecular weight substances like **Heparin** (high MW) and **Insulin** (large peptide) are notable exceptions that do not cross the placental barrier. * **Option D:** The placenta contains efflux transporters like **P-glycoprotein (P-gp)** and BCRP. These act as a protective mechanism by pumping certain xenobiotics and drugs back into the maternal circulation. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of Thumb:** Drugs with MW ** 1000 Daltons** (like Heparin) do not. * **Warfarin vs. Heparin:** Warfarin is teratogenic (crosses placenta); Heparin is the anticoagulant of choice in pregnancy (does not cross). * **Local Anesthetics:** During labor, lidocaine (a weak base) can undergo ion trapping in the fetus, potentially leading to neonatal depression.

Q: A 57-year-old man receiving mechanical ventilation contracts pneumonia caused by Pseudomonas aeruginosa. The patient is given antibiotic therapy with ceftazidime and gentamicin. Assuming the half-life of gentamicin is 3 hours in this patient, what percentage of the initial dose will most likely remain in his body 6 hours later?

25%. ### Explanation **1. Why the Correct Answer is Right:** The question tests the fundamental concept of **Half-life ($t_{1/2}$)**, which is the time required for the plasma concentration of a drug to decrease by 50%. * **Initial Dose:** 100% * **After 1 Half-life (3 hours):** The concentration drops by half. (100% $\div$ 2 = **50%**) * **After 2 Half-lives (6 hours):** The concentration drops by half again. (50% $\div$ 2 = **25%**) Since the patient’s $t_{1/2}$ is 3 hours, a 6-hour interval represents exactly **two half-lives**. Therefore, 25% of the initial dose remains in the body. **2. Why the Incorrect Options are Wrong:** * **Option A (12.5%):** This represents the amount remaining after **three** half-lives (3 $\times$ 3 = 9 hours). * **Option C (33%):** This is a distractor; drug elimination follows exponential (first-order) decay, not a simple linear division into thirds. * **Option D (50%):** This represents the amount remaining after only **one** half-life (3 hours). **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **First-Order Kinetics:** Most drugs (including Gentamicin) follow first-order kinetics, where a **constant fraction** of the drug is eliminated per unit time. * **Steady State:** It takes approximately **4 to 5 half-lives** for a drug to reach steady-state concentration or to be completely eliminated from the body. * **Gentamicin Dosing:** Gentamicin is an aminoglycoside excreted renally. In clinical practice, if a patient has renal impairment, the $t_{1/2}$ increases significantly, requiring dosage adjustment to prevent nephrotoxicity and ototoxicity. * **Synergy:** The combination of a Cell Wall Inhibitor (Ceftazidime) and a Protein Synthesis Inhibitor (Gentamicin) provides **synergistic bactericidal action** against *Pseudomonas*.

Question 1

If a drug has a Volume of Distribution (Vd) equal to 60L, what does this indicate about the drug's distribution?

Accepted Answer

The drug is significantly sequestered in tissue sites.

Answer

The drug is highly bound to plasma proteins.

Answer

The drug is easily excreted.

Answer

None of the above.

Question 2

A clinical pharmacologist is gathering pharmacokinetic data during clinical trials of a new antimicrobial agent. He has already determined that the half-life of this drug is 4 hours. He began a continuous intravenous drip 24 hours ago at a rate of 10 mg/min. Blood tests after 24 hours reveal that the patient's drug plasma concentration is 20 mg/L. What is the clearance of this agent?

Accepted Answer

0.5 L/min

Answer

2 L/min

Answer

10 L/min

Answer

50 L/min

Question 3

Which of the following drugs is NOT metabolized by acetylation?

Accepted Answer

Metoclopramide

Answer

Isoniazid

Answer

Dapsone

Answer

Hydralazine

Question 4

Which of the following is NOT a metabotropic receptor?

Accepted Answer

Beta receptor for norepinephrine

Answer

GABA receptor

Answer

Acetylcholine receptor

Answer

Alpha receptor for norepinephrine

Question 5

What causes the rapid awakening from a single bolus dose of Propofol?

Accepted Answer

Redistribution

Answer

Excretion

Answer

Biotransformation

Answer

D-Methylation

Question 6

A drug administered through which of the following routes undergoes high first-pass metabolism?

Accepted Answer

Oral

Answer

Sublingual

Answer

Intravenous (I.V.)

Answer

Intramuscular (I.M.)

Question 7

Which of the following statements regarding transfer of drugs across the placenta is FALSE?

Accepted Answer

Ion trapping of acidic drugs occurs in the placenta.

Answer

Transfer across the placenta is lesser in early pregnancy.

Answer

All drugs to some extent can cross the placenta except heparin and insulin.

Answer

P–glycoprotein is present in the placenta.

Question 8

Which of the following statements is true about first-order kinetics?

Accepted Answer

The rate of elimination increases with an increase in drug concentration and decreases with a decrease in drug concentration.

Answer

Very few drugs follow first-order kinetics.

Answer

The half-life (t1/2) is constant.

Answer

Salicylates follow first-order kinetics throughout their therapeutic ranges.

Question 9

A 57-year-old man receiving mechanical ventilation contracts pneumonia caused by Pseudomonas aeruginosa. The patient is given antibiotic therapy with ceftazidime and gentamicin. Assuming the half-life of gentamicin is 3 hours in this patient, what percentage of the initial dose will most likely remain in his body 6 hours later?

Accepted Answer

25%

Answer

12.5%

Answer

33%

Answer

50%

Question 10

Which statement is not true regarding therapeutic drug monitoring (TDM)?

Accepted Answer

TDM is performed when the clinical response to a drug can be easily measured.

Answer

TDM is indicated for drugs with a narrow therapeutic index.

Answer

Digoxin is a drug for which TDM is commonly performed.

Answer

TDM is useful when a drug exhibits erratic pharmacokinetics.

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?